Evergreen Investment Partners logo

Evergreen Investment Partners

Europe, Nordrhein-Westfalen, Germany, England

Description

Evergreen Investment Partners is a prominent private equity firm headquartered in Munich, Germany, specializing in investments in small and medium-sized enterprises (SMEs) across the German-speaking DACH region (Germany, Austria, and Switzerland). The firm focuses on acquiring majority stakes in established companies, aiming to foster sustainable growth and operational excellence. Their investment philosophy centers on a partnership approach, working closely with management teams to unlock potential and drive value creation.

The firm's investment strategy is versatile, encompassing growth capital, succession solutions for family-owned businesses, corporate carve-outs, and buy-and-build strategies. Evergreen Investment Partners targets companies with revenues typically ranging from EUR 10 million to EUR 200 million and a minimum EBITDA of EUR 2 million. They are sector-agnostic but show particular interest in industrials, business services, healthcare, and consumer goods. Their commitment extends beyond mere capital injection, providing strategic guidance, operational support, and access to their extensive network to facilitate expansion and market leadership.

Evergreen Investment Partners typically deploys equity investments ranging from EUR 5 million to EUR 50 million per transaction. This flexible check size allows them to engage with a diverse portfolio of companies, from established mid-market players seeking expansion capital to businesses undergoing ownership transitions. The firm emphasizes a long-term investment horizon, aligning their interests with those of their portfolio companies to achieve robust and lasting success. Their disciplined approach to due diligence and post-acquisition value creation underscores their reputation as a reliable and value-adding partner in the European private equity landscape.

Investor Profile

Evergreen Investment Partners has backed more than 31 startups, with 2 new investments in the last 12 months alone. The firm has led 2 rounds, about 6% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in South Korea.
  • Strong thematic focus on Artificial Intelligence (AI), Information Technology, Software.
  • Typical check size: $5.4M – $54M.

Stage Focus

  • Seed (52%)
  • Series A (26%)
  • Series Unknown (10%)
  • Series C (6%)
  • Private Equity (3%)
  • Series B (3%)

Country Focus

  • South Korea (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Information Technology
  • Software
  • Internet
  • Marketing
  • Saas
  • Video
  • Fitness
  • Human Computer Interaction
  • Virtual Reality
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Evergreen Investment Partners frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
F
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Hana Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
FV
North America, California, United States, Los Angeles
Co-Investments: 1
Korea Credit Guarantee Fund
Asia, Seoul-t'ukpyolsi, South Korea, Mapo
Co-Investments: 2
D·CAMP
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Big Basin Capital
North America, California, United States, Cupertino
Co-Investments: 1
Daekyo Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
DA Value Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
VentureSquare
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2

What are some of recent deals done by Evergreen Investment Partners?

Inventera Pharmaceuticals

Seocho, Seoul-t'ukpyolsi, South Korea

Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.

BiotechnologyPharmaceutical
Series COct 30, 2024
Amount Raised: $13,428,092
Storelink

Seoul, Seoul-t'ukpyolsi, South Korea

Storelink is an open market optimization platform that analyzes and processes accurate online sales data.

MarketingProduct Research
Series CAug 19, 2024
Amount Raised: $15,010,436
Polaris3D

Pohang, Kyongsang-bukto, South Korea

Polaris3d offers indoor autonomous navigating solution.

NavigationRobotics
Series BJun 3, 2024
Amount Raised: $10,934,619
Adler

Seoul, Seoul-t'ukpyolsi, South Korea

Adler makes 3D web - 1 Person, 1 Virtual Universe

Developer PlatformPaaSSocial Media
SeedFeb 2, 2024
Amount Raised: $1,120,298
TeamElysium

Seocho, Seoul-t'ukpyolsi, South Korea

TeamElysium is a medical software development company.

FitnessMedicalSoftware
SeedJan 30, 2024
Movic Lab

Incheon, Inch'on-jikhalsi, South Korea

Movic Lab provides smart factory solutions based on AI technology.

Artificial Intelligence (AI)Business DevelopmentHardwareInformation Technology
SeedDec 22, 2023
Amount Raised: $1,154,059
mAy-I

Seocho, Seoul-t'ukpyolsi, South Korea

mAy-I develops advanced machine vision tracking solution.

Computer VisionInformation TechnologyVideo
Series ADec 13, 2023
Amount Raised: $4,640,270
Dareesoft

Seongnam, Kyonggi-do, South Korea

Dareesoft is a company that provides road hazard information service in real time.

ConsultingInformation TechnologyService Industry
Series ANov 25, 2022
Amount Raised: $4,118,123
Adler

Seoul, Seoul-t'ukpyolsi, South Korea

Adler makes 3D web - 1 Person, 1 Virtual Universe

Developer PlatformPaaSSocial Media
SeedSep 1, 2022
Amount Raised: $2,200,000
Langcode

Seocho, Seoul-t'ukpyolsi, South Korea

Langcode is a conversational AI-powered platform that provides B2B SaaS and 3C solutions for businesses.

Artificial Intelligence (AI)Information TechnologySaaSSoftware
SeedJun 23, 2022